These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21130399)

  • 1. [Study of the expression of Aurora kinases in renal cell carcinoma].
    Mathieu R; Patard JJ; Stock N; Rioux-Leclercq N; Guillé F; Fergelot P; Bensalah K
    Prog Urol; 2010 Dec; 20(13):1200-5. PubMed ID: 21130399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Aurora-A expression in renal cell carcinoma.
    Kurahashi T; Miyake H; Hara I; Fujisawa M
    Urol Oncol; 2007; 25(2):128-33. PubMed ID: 17349527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression.
    Kruck S; Bedke J; Hennenlotter J; Ohneseit PA; Kuehs U; Senger E; Sievert KD; Stenzl A
    Oncol Rep; 2010 Jan; 23(1):159-63. PubMed ID: 19956876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
    Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
    Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells.
    Cha TL; Chuang MJ; Wu ST; Sun GH; Chang SY; Yu DS; Huang SM; Huan SK; Cheng TC; Chen TT; Fan PL; Hsiao PW
    Clin Cancer Res; 2009 Feb; 15(3):840-50. PubMed ID: 19188154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora kinases as prognostic biomarkers in ovarian carcinoma.
    Mendiola M; Barriuso J; Mariño-Enríquez A; Redondo A; Domínguez-Cáceres A; Hernández-Cortés G; Pérez-Fernández E; Sánchez-Navarro I; Vara JA; Suárez A; Espinosa E; González-Barón M; Palacios J; Hardisson D
    Hum Pathol; 2009 May; 40(5):631-8. PubMed ID: 19157502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of S100 protein in renal cell carcinoma and its relation with P53].
    Yang JF; Zhang XY; Qi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters.
    Turunc T; Bal N; Dirim A; Kuzgunbay B; Gul U; Ozkardes H
    Urology; 2010 Sep; 76(3):765.e8-13. PubMed ID: 20605199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
    Islam AH; Ehara T; Kato H; Hayama M; Kobayashi S; Igawa Y; Nishizawa O
    J Urol; 2004 Mar; 171(3):1319-23. PubMed ID: 14767341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIGH3 is overexpressed in clear cell renal cell carcinoma.
    Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
    Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effect of Aurora kinase targeting in mesothelioma.
    Crispi S; Fagliarone C; Biroccio A; D'Angelo C; Galati R; Sacchi A; Vincenzi B; Baldi A; Verdina A
    Lung Cancer; 2010 Dec; 70(3):271-9. PubMed ID: 20371132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma].
    Tan WL; Xiong L; Zheng SB; Yu ZC; Qi H; Du YJ; Wu P
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1316-8. PubMed ID: 16982445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
    Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S
    Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
    Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.